UNSPSC 51144128: Metamfetamine or methamphetamine

This classification denotes a cns stimulant with the molecular formula C10H15N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 44RAL3456C, chemically known as (s)-(+)-n,alpha,dimethylphenethylamine but more generally known as metamfetamine, which bears US NIH Compound Identifier 10836. European Medicines Agency schedules Metamfetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08809MIG. The term METAMFETAMINE is an International Non-Proprietary Name.

UNSPSC 51144128 Methamphetamine (Commodity) shows a mismatch between its nominal scope and recent state and local solicitation activity. The code's name references controlled substances, yet the three recent opportunities posted under it—Seminole County's naloxone and drug deactivation systems procurement, Texas HHS's Therapeutic Pharmacy Initiative direct-to-manufacturer RFI, and MMCAP's generic multi-source pharmaceuticals and OTC products RFP—involve harm-reduction medical supplies, pharmacy benefit management, and legitimate pharmaceutical distribution. None of these solicitations concern the purchase or distribution of methamphetamine itself. State and local governments do not procure controlled substances through open competitive bidding; the tagging reflects a cataloging error rather than an active procurement category.

The three opportunities that carry this code are otherwise diverse in scope and geography. Seminole County, Florida (IFB 60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries. Texas Health and Human Services Commission (RFI HHS0017013, due April 3, 2026) gathered vendor information on direct-to-manufacturer prescription programs to support state employee and Medicaid pharmacy benefit objectives. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued a multi-state cooperative purchasing RFP (S1070000015802, due March 26, 2026) for generic and OTC pharmaceutical products to supply participating state and local facilities across Minnesota and Oregon. These solicitations span health agencies, a county community health operation, and a multistate cooperative purchasing vehicle—none of which reflects a coherent procurement pattern under the methamphetamine code itself. The code shows no relevant recent activity for business development purposes.